At this year’s RSNA, computer-aided detection (CAD) solutions target MRI. These new CAD systems include:
• VividLook MRI prostate analysis solution, provides more diagnostic information by utilizing all available time points (ATP), creating colorized images based on signal changes defined by tumor physiology. This post processing software package is designed to provide a reliable means of visualizing the presence and pattern of contrast induced enhancement of MRI images in the prostate, helping radiologists distinguish benign from malignant lesions.
• SpectraLook CAD technology is designed to assist radiologists in distinguishing potential cancers in the breast as part of their overall analysis of the MRI procedure results. It provides radiologists with more diagnostic information by creating colorized images based on direct signal changes due to contrast agent influx and efflux rates using key physiological measures that relate to tumor physiology. These physiological markers can aid in the analysis of large MR data sets.
• PrecisionPoint, iCAD’s interventional planning solution for breast MRI, provides radiologists with an automatic calculation of the location and depth of a targeted region of interest making biopsies easier, faster, and more reliable for both grid and post and pillar methods. PrecisionPoint is an integrated module within CADvue, iCAD’s MRI review software solution. Using CADvue and PrecisionPoint, radiologists have a quick, easy way to secure all the necessary data for an interventional procedure, streamlining their planning and performance of MRI-guided percutaneous breast biopsies.
• CADvue is iCAD’s MRI review software and analysis solution that facilitates the analysis of ATP colorized images and quantitative data. CADvue allows the user to create standard and customized reports that enable the radiologist to communicate time-sensitive breast and prostate MR study results to referring physicians. CADvue software also provides an efficient method for clinicians to compare studies of the same patient performed over time to assess the morphology and kinetic changes. CADvue compares several parameters including EVF, PERM, and volume of selected regions of interest enabling improved quantitative analysis.
September 12, 2024 
